Additionally, the study revealed that SIGLEC9 is predominantly expressed on macrophages and T-cells, with high levels of SIGLEC9+ TAMs and SIGLEC9+ T-cells observed in cervical cancer tissues. This evidence concerns the gene SIGLEC9 and cervical cancer.